Are you looking quote for part NDC00019-5505-04? The Mallinckrodt Inc-manufactured component (CAGE Code: 37940) is documented under NSN 6505-01-239-6931 as Ioxaglate Meglumine. For the fastest quote, please complete our RFQ form with details about NDC00019-5505-04. We guarantee a response within 15 minutes.
ASAP Components provides the verified NDC00019-5505-04, classified under INC 66566, FSG , FSC , NIIN 01-239-6931, and NCB 01. Submit your requirements today to receive immediate pricing and availability information.
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-01-239-6931 Item PartTypeName: IOXAGLATE MEGLUMINE AND IOXAGLAT | 6505 | 012396931 | Y | |||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| U | ||||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| 5505-042 | 5 | 2 | 3 |
| MRC | Criteria | Characteristic |
|---|---|---|
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 30.000 MILLILITERS |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| CSGS | ADMINISTRATION | INTRA-ARTERIAL AND INTRAVENOUS |
| FEAT | SPECIAL FEATURES | EACH VIAL CONTAINS IOXAGLATE MEGLUMINE 39.3 AND IOXAGLATE SODIUM 19.6; STERILE |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| End Use : 40100 | Pharmaceutical preparations |
|---|---|
| Schedule B : 3006300000 (NAICS 325413) | Opacifying preparations for x-ray examinations; diagnostic reageants designed to be administered to the patient |
| SITC : 54193 | Opacifying preparations for x-ray examinations; diagnostic reagents |
| CRITL | The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. |
|---|---|
| HMIC | Y - Indicates information is in the hazardous materials information resource system (hmirs). |
| PMIC | U - Precious metal content is unknown |
